We are live on ! Find out more
AC

Armistice Capital Portfolio holdings

AUM $5.62B
1-Year Est. Return 36.06%
This Fund
S&P 500
This Quarter Est. Return
-7.28%
1 Year Est. Return
+36.06%
3 Year Est. Return
+44.14%
5 Year Est. Return
+38.37%
10 Year Est. Return
+188.88%
AUM
$6.53B
AUM Growth
-$382M
Cap. Flow
+$195M
Cap. Flow %
2.99%
Top 10 Hldgs %
59.37%
Holding
305
New
83
Increased
54
Reduced
76
Closed
50

Top Buys

Rank Stock Value
1
PTCT icon
PTC Therapeutics
PTCT
+$108M
2
BUD icon
AB InBev
BUD
+$39.8M
3
IRWD icon
Ironwood Pharmaceuticals
IRWD
+$33.9M
4
CRL icon
Charles River Laboratories
CRL
+$32M
5
CL icon
Colgate-Palmolive
CL
+$27M

Top Sells

Rank Stock Value
1
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
+$93.3M
2
PFE icon
Pfizer
PFE
+$76.9M
3
JNJ icon
Johnson & Johnson
JNJ
+$53.7M
4
INCY icon
Incyte
INCY
+$46.6M
5
NBIX icon
Neurocrine Biosciences
NBIX
+$45.7M

Sector Composition

Rank Sector Weight
1 Healthcare 34.38%
2 Consumer Staples 6.6%
3 Technology 4.23%
4 Consumer Discretionary 3.89%
5 Communication Services 1.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
YUM icon
76
Yum! Brands
YUM
$41.3B
$13.5M 0.21%
107,737
-40,263
-27% -$5.3M
TGT icon
77
Target
TGT
$67.6B
$13.1M 0.2%
+118,225
New +$15M
LYV icon
78
Live Nation Entertainment
LYV
$42.7B
$12.3M 0.19%
148,088
-70,912
-32% -$6.18M
MCD icon
79
McDonald's
MCD
$194B
$12.3M 0.19%
46,543
-23,457
-34% -$6.69M
CMG icon
80
Chipotle Mexican Grill
CMG
$42.5B
$11.8M 0.18%
321,250
+78,750
+32% +$3.07M
FL
81
DELISTED
Foot Locker
FL
$11.5M 0.18%
664,657
+174,657
+36% +$3.91M
PM icon
82
Philip Morris
PM
$292B
$11.2M 0.17%
121,249
-102,751
-46% -$9.89M
DYN icon
83
Dyne Therapeutics
DYN
$4.97B
$10.8M 0.16%
1,200,000
+288,000
+32% +$3.1M
TMO icon
84
Thermo Fisher Scientific
TMO
$213B
$10.6M 0.16%
21,000
-24,000
-53% -$12.8M
ZURA icon
85
Zura Bio
ZURA
$546M
$10.4M 0.16%
1,580,000
+630,000
+66% +$4.21M
BABA icon
86
Alibaba
BABA
$304B
$10.4M 0.16%
120,000
-180,000
-60% -$16.5M
GSK icon
87
GSK
GSK
$105B
$10.3M 0.16%
285,000
-15,000
-5% -$532K
ASRT
88
DELISTED
Assertio
ASRT
$10M 0.15%
+261,600
New +$15.3M
CELH icon
89
Celsius Holdings
CELH
$6.28B
$9.95M 0.15%
+174,000
New +$9.78M
PATH icon
90
UiPath
PATH
$6.98B
$9.79M 0.15%
572,189
-91,811
-14% -$1.53M
ADBE icon
91
Adobe
ADBE
$101B
$9.08M 0.14%
17,804
-6,196
-26% -$3.25M
LULU icon
92
lululemon athletica
LULU
$14.2B
$8.84M 0.14%
22,932
-12,068
-34% -$4.61M
APLT
93
DELISTED
Applied Therapeutics
APLT
$8.47M 0.13%
+3,400,000
New +$5.6M
NVDA icon
94
NVIDIA
NVDA
$5.38T
$7.78M 0.12%
178,790
-1,210
-0.7% -$54.2K
FREE
95
DELISTED
Whole Earth Brands, Inc. Class A Common Stock
FREE
$7.74M 0.12%
2,150,000
– –
GERN icon
96
Geron
GERN
$1.01B
$7.68M 0.12%
3,624,000
-876,000
-19% -$2.38M
TSM icon
97
TSMC
TSM
$2.17T
$7.65M 0.12%
88,000
+16,000
+22% +$1.51M
CROX icon
98
Crocs
CROX
$6.6B
$7.35M 0.11%
83,360
-11,640
-12% -$1.2M
AQST icon
99
Aquestive Therapeutics
AQST
$483M
$7.34M 0.11%
4,800,000
+3,642,000
+315% +$6.26M
GB
100
DELISTED
Global Blue Group Holding
GB
$7.3M 0.11%
1,199,875
-325,125
-21% -$1.73M
2 3
4
5 6

Similar funds

CRC
Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return
RMDI
R.M. Davis Inc Portland, Maine $5.63B AUM 21.26% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
EW
Evoke Wealth Los Angeles, California $5.57B AUM 23.85% 1-Year Est. Return
O
Ossiam Paris, France $5.69B AUM 30.95% 1-Year Est. Return
DSC
Donald Smith & Co New York $5.56B AUM 47.13% 1-Year Est. Return
ACM
Altimeter Capital Management Boston, Massachusetts $5.7B AUM 36.74% 1-Year Est. Return
PI
PGGM Investments Zeist, Netherlands $5.7B AUM 17.05% 1-Year Est. Return

Armistice Capital's Q3 2023 Portfolio in Review

As of Q3 2023, Armistice Capital held 305 positions worth $6.53B, down 5.5% from $6.91B the previous quarter. Its ten largest holdings account for 59% of the portfolio.

Armistice Capital's Q3 2023 filing shows 83 new, 54 increased, 76 reduced and 50 closed positions. Its largest new stake was AB InBev: 703,000 shares worth $38.9M. The largest sale was Mirati Therapeutics, Inc. Common Stock, an estimated $93.3M.

By sector, the portfolio is most concentrated in Healthcare at 34% of assets, down from 39% a quarter earlier, followed by Consumer Staples and Technology.

  • Armistice Capital's largest Q3 2023 buy was AB InBev: 703,000 shares worth $38.9M.
  • Armistice Capital added most to PTC Therapeutics in Q3 2023, an estimated $108M increase.
  • Armistice Capital's biggest Q3 2023 reduction was Mirati Therapeutics, Inc. Common Stock, cutting an estimated $93.3M.
  • Armistice Capital fully exited Pfizer in Q3 2023, selling an estimated $76.9M.
  • Armistice Capital's ten largest holdings make up 59% of its $6.53B portfolio in Q3 2023.
  • Armistice Capital opened 83 new positions and closed 50 in Q3 2023.
  • Armistice Capital's portfolio value fell 5.5% quarter-over-quarter to $6.53B.

Based on Armistice Capital's 13F filing for Q3 2023, filed 14 Nov 2023.